The 2 ‘ 3 ‘ -cGAMP analogue, c-di-AMP, activates the STING pathway to induce apoptosis in estrogen receptor-negative breast cancer cells, resulting in the release of tumor antigens (TAs) and propagation of the cancer-immunity cycle (30). This evidence concerns the gene STING1 and cancer.